Table 4.
Characteristics and outcome of patients whose pathology of the second TUR was pT0
| Characteristics | BCG(+) (n = 12) | BCG(−) (n = 19) | p-value | |||
|---|---|---|---|---|---|---|
| No. of recurrent cases | 1 | (8 %) | 11 | (58 %) | ||
| Recurrence within 1 year | 1 | (8 %) | 8 | (42 %) | ||
| Median follow-up period (months; range) | 17.8 | (5.6–33.9) | 11.4 | (4.1–37.6) | ||
| Median age (years; range) | 65.5 | (39–86) | 71.9 | (45–84) | 0.22 | |
| Gender | Male | 8 | (67 %) | 15 | (79 %) | 0.89 |
| Female | 4 | (33 %) | 4 | (21 %) | ||
| Tumor size | <3 cm | 8 | (67 %) | 11 | (58 %) | 0.30 |
| ≥3 cm | 4 | (33 %) | 8 | (42 %) | ||
| Tumor number | Single | 6 | (50 %) | 11 | (58 %) | 0.63 |
| Multiple | 6 | (50 %) | 8 | (42 %) | ||
| Concomitant CIS | Negative | 8 | (67 %) | 19 | (100 %) | 0.19 |
| Positive | 4 | (33 %) | 0 | (0 %) | ||
| EAU recurrence risk | <9 | 11 | (92 %) | 19 | (100 %) | 0.07 |
| ≥10 | 1 | (8 %) | 0 | (0 %) | ||
| Location of the recurrent tumor† | Same | 1 | (8 %) | 1 | (5 %) | |
| Different | 0 | (0 %) | 10 | (53 %) | ||
† compared with the initial TUR